Latest News for: us fda
Edit
US FDA approves higher dose of Novo Nordisk's hit weight-loss drug Wegovy
Business Line 20 Mar 2026
The approval comes as Novo Nordisk ...
Edit
US FDA Approves GSK's Drug for Liver Disease Related Itching
US News 19 Mar 2026
March 19 (Reuters) - The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by a type of liver... .
Edit
Lynavoy (linerixibat) approved by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC) (Form 6-K) (GSK plc)
Public Technologies 19 Mar 2026
Lynavoy (linerixibat) approved by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC) ... GSK) today announced that the US Food and Drug Administration (FDA) has ...
Edit
US FDA Approves J&J's Oral Psoriasis Pill
US News 18 Mar 2026
By Sriparna RoyMarch 18 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, the... .
Edit
TERUMO AORTIC ANNOUNCES US FDA BREAKTHROUGH DEVICE DESIGNATION FOR FENESTRATED TREO® (Terumo Corporation)
Public Technologies 17 Mar 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 130218250) .
Edit
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
Nasdaq Globe Newswire 16 Mar 2026
Edit
Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
PR Newswire 16 Mar 2026
If approved, this would mark a new indication for ILUMYA following its US FDA approval in 2018 for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Edit
RXC008 Receives US FDA Fast Track Designation (Redx Pharma Ltd)
Public Technologies 10 Mar 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit
Who is Vinay Prasad? US FDA vaccine chief to step down next month
Live Mint 07 Mar 2026
Dr Vinay Prasad is a former epidemiology professor at the University of California at San Francisco. Prasad joined the FDA in May 2025, replacing Peter Marks ....
Edit
The Milton Standard Journal
04 Mar 2026
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) ...
The Milton Standard Journal
04 Mar 2026
Edit
XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy
PR Newswire 02 Mar 2026
Edit
Biocon wins USFDA approval for generic weight-loss drug Liraglutide
Business Line 25 Feb 2026
Approval marks Biocon’s entry into the high-growth US obesity treatment market ....
- 1
- 2
- Next page »